FDA Should Designate New Nitroglycerin Reference Product, Firms Say
Executive Summary
FDA should choose a new reference product for nitroglycerin, manufacturers suggested in letters to FDA requesting hearings on the proposed withdrawal of ANDAs for nitroglycerin products.